Evidence map›Paper›PMID 32929660›Full record

ArticleMedical & biological engineering & computing2020

GFNB: Gini index-based Fuzzy Naive Bayes and blast cell segmentation for leukemia detection using multi-cell blood smear images.

Biplab Kanti Das, Himadri Sekhar Dutta

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Biplab Kanti DasCalcutta Institute of Technology, Howrah, West Bengal, India. bkdmca118@gmail.com.
Himadri Sekhar DuttaKalyani Government Engineering College, Kalyani, West Bengal, India.
Calcutta Research Group · INUniversity of Kalyani · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The blood cell counting and classification ensures the evaluation and diagnosis of a number of diseases. The analysis of white blood cells (WBCs) permits us to detect the acute lymphoblastic leukemia (ALL), a type of blood cancer that causes fatality when untreated. At present, the morphological analysis of blood cells is performed manually by skilled operators, which holds numerous drawbacks. The manual techniques for leukemia detection are time-consuming and show less accurate results. Hence, there is a need for an automatic method for detecting leukemia. In order to overcome the demerits associated with the manual methods of counting and classifying, an automatic method of blast cell counting and leukemia classification is progressed. This paper proposes a leukemia detection method, using the Gini index-based Fuzzy Naive Bayes (GFNB) classifier that is the integration of Gini index and Fuzzy Naive Bayes classifier. Initially, the input multi-cell blood smear image is subjected to pre-processing, and the blast cell is segmented using the adaptive thresholding. Then, the blast cells are counted using the proposed classifier so as to decide the presence of leukemia for the effective diagnosis. Experimental analysis using the ALL-IDB1 database confirms that the proposed method operates better than the existing methods in terms of accuracy, specificity, and sensitivity that are found to be 0.9591, 0.9599, and 1, respectively. The experimental results reveal that the proposed method is reliable and accurate. Also, the proposed system can help the physicians to improve and speed up their process.Graphical abstract Leukemia is caused by the excess production of the immature leucocytes in the bone marrow that expose the human body to lose the tendency to fight against the diseases. Leukemia classification is highly needed as in the later stage, failure of the diagnosis steps may lead to the death of the person. Moreover, some countries do not have any study against the diagnosis steps of leukemia and it highly exists among the low-income people. In order to analyze the type of leukemia and to provide an effective diagnosis strategy, the paper presents a fast and highly accurate classification method. The main aim of the paper is to propose a method to perform the leukemia classification through the segmentation and classification of the WBC cells using the multi-cell blood smear images. The major steps involved in the leukemia classification are pre-processing, segmentation, feature extraction, and classification. The input blood smear image is enhanced in the pre-processing step and the pre-processed image is subjected to segmentation using the LUV color transformation and Adaptive Thresholding strategy. The features are extracted from the individual segments and they are presented to the classifier for the classification. The features extracted are shape, texture, and count of the blast cells, for which the grid-based shape extraction, local gradient pattern (LGP)-based texture features, and pixel threshold-based counting of the blast cells are employed. The proposed classifier is developed using the Gini index and Fuzzy Naive Bayes classifier.

Indexed as

Bayes TheoremDiagnosis, Computer-AssistedFuzzy LogicHematologic TestsHumansImage Processing, Computer-AssistedLeukemiaLeukocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaSensitivity and SpecificityBlast cell identificationBlood smear imageFuzzy Naïve BayesGini indexLeukemia classification

Identifiers

PMID32929660
OpenAlexW3086882437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.